Tara Harding, FNP-C | |
612 Center Ave N, Ashley, ND 58413-7013 | |
(701) 288-3448 | |
(701) 288-3213 |
Full Name | Tara Harding |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 612 Center Ave N, Ashley, North Dakota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578962130 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | R34495 (North Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tara Harding, FNP-C 3000 N 14th St Ste 3a, Bismarck, ND 58503-0697 Ph: (701) 288-3448 | Tara Harding, FNP-C 612 Center Ave N, Ashley, ND 58413-7013 Ph: (701) 288-3448 |
News Archive
Tissue oxygenation is a measure of the oxygen level in biological tissue and is a useful clinical biomarker for tissue viability. Abnormal levels may indicate the presence of conditions such as sepsis, diabetes, viral infection, or pulmonary disease, and effective monitoring is important for surgical guidance as well as medical care.
MPI Research announced today that Thomas Laughlin will join the company as Executive Vice President of Sales and Marketing and will be a member of the company's Corporate Management Team. Laughlin's 30+ years of executive experience span several of the world's largest and most successful healthcare products companies.
Bavarian Nordic today provided updated data from its clinical studies with its breast cancer vaccine, MVA-BN(R)-HER2, in development as therapy of metastatic breast cancer patients whose tumours over-express HER2.
DaVita Clinical Research, a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen Research Grant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research.
The longer the insomnia, junctions of cerebral blood vessels begin to degrade. In search of the answer to why do we sleep, research conducted at the Mexican Metropolitan Autonomous University (UAM) revealed that chronic sleep loss can cause certain neurotoxic molecules, which normally circulate in the blood, to be transported to the central nervous system and interfere with the function of neurons.
› Verified 7 days ago
Cori Lynn Randall, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 612 Center Ave N, Ashley, ND 58413 Phone: 701-288-3433 | |
Dan Lee Beach, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 612 Center Ave N, Ashley, ND 58413 Phone: 701-288-3448 Fax: 701-288-3937 |